Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMA_PREPAIRE: Intrauterine PRP in Recurrent Implantation Failure and Refractory Thin Endometrium
NCT07455773Not yet recruiting
- Sponsor
- ASL Asti
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Open-label trial of platelet-rich plasma in Recurrent Implantation Failure (RIF) and thin endometrium (2 arms), sponsored by ASL Asti. Primary endpoint: Achievement of Endometrial Thickness >= 7 mm at 14 days. Planned start May 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
Recurrent Implantation Failure (RIF)thin endometrium
Beyond the preview
Go deeper on NCT07455773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07455773.